{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T23:23:20Z","timestamp":1788477800866,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007048","name":"Mayo Foundation for Medical Education and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.jaip.2023.02.017","type":"journal-article","created":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T11:47:28Z","timestamp":1677584848000},"page":"2542-2546","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Increased Excretion of Mast Cell Mediator Metabolites During Mast Cell Activation Syndrome"],"prefix":"10.1016","volume":"11","author":[{"given":"Joseph H.","family":"Butterfield","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2023.02.017_bib1","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.jaci.2010.08.035","article-title":"Mast cell activation syndrome: proposed diagnostic criteria","volume":"126","author":"Akin","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.02.017_bib2","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.jaip.2019.01.006","article-title":"Proposed diagnostic algorithm for patients with suspected mast cell activation syndrome","volume":"7","author":"Valent","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.02.017_bib3","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jaci.2021.08.007","article-title":"Defining baseline variability of serum tryptase levels improves accuracy in identifying anaphylaxis","volume":"149","author":"Mateja","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.02.017_bib4","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/ng.3696","article-title":"Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number","volume":"48","author":"Lyons","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaip.2023.02.017_bib5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.7326\/0003-4819-105-1-65","article-title":"Glucagon reversal of hypotension in a case of anaphylactoid shock","volume":"105","author":"Zaloga","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaip.2023.02.017_bib6","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1067\/mai.2001.119028","article-title":"Emergency department anaphylaxis: a review of 142 patients in a single year","volume":"108","author":"Brown","year":"2001","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.02.017_bib7","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/292454a0","article-title":"Inhibition of basophil histamine release by antiinflammatory steroids","volume":"292","author":"Schleimer","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.jaip.2023.02.017_bib8","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1164\/ajrccm\/140.4.951","article-title":"Dexamethasone does not inhibit the release of mediators from human mast cells residing in airway, intestine, or skin","volume":"140","author":"Cohan","year":"1989","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jaip.2023.02.017_bib9","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jaci.2020.01.017","article-title":"Anaphylaxis\u2014a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis","volume":"145","author":"Shaker","year":"2002","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.02.017_bib10","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1159\/000144042","article-title":"Prevention of mast cell activation disorder-associated clinical sequelae of excessive prostaglandin D2 production","volume":"147","author":"Butterfield","year":"2007","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2023.02.017_bib11","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.prostaglandins.2009.01.001","article-title":"Survey of aspirin administration in systemic mastocytosis","volume":"88","author":"Butterfield","year":"2009","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.jaip.2023.02.017_bib12","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jaip.2014.06.011","article-title":"Mast cell activation syndrome: Improved identification by combined determinations of serum tryptase and 24-hour urine 11\u03b2-prostaglandin 2\u03b1","volume":"2","author":"Ravi","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.02.017_bib13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000503964","article-title":"Survey of mast cell mediator levels from patients presenting with symptoms of mast cell activation","volume":"181","author":"Butterfield","year":"2020","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2023.02.017_bib14","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jaci.2021.08.007","article-title":"Defining baseline variability of serum tryptase levels improves accuracy in identifying anaphylaxis","volume":"149","author":"Mateja","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.02.017_bib15","first-page":"36","article-title":"Mastocytosis without urticaria pigmentosa: a frequently unrecognized cause of recurrent syncope","volume":"95","author":"Roberts","year":"1982","journal-title":"Trans Assoc Am Phys"},{"key":"10.1016\/j.jaip.2023.02.017_bib16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1523-1747.ep12468945","article-title":"Biochemical diagnosis of systemic mast cell disorders","volume":"96","author":"Roberts","year":"1991","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2023.02.017_bib17","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000237133","article-title":"Cysteinyl leukotriene production in anaphylactic reactions","volume":"108","author":"Denzlinger","year":"1995","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2023.02.017_bib18","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.clinbiochem.2016.02.007","article-title":"Analytical and clinical validation of an LC-MS\/MS method for urine leukotriene E4: a marker of systemic mastocytosis","volume":"40","author":"Lueke","year":"2016","journal-title":"Clin Biochem"},{"key":"10.1016\/j.jaip.2023.02.017_bib19","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1016\/j.jaip.2020.02.021","article-title":"The utility of measuring urinary metabolites of mast cell mediators in systemic mastocytosis and mast cell activation syndrome","volume":"8","author":"Butterfield","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.02.017_bib20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0952-3278(91)90138-U","article-title":"Leukotriene C4 formation by enriched human basophil preparations from normal and asthmatic subjects","volume":"44","author":"Van der Donk","year":"1991","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.jaip.2023.02.017_bib21","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1172\/JCI110938","article-title":"Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells","volume":"71","author":"Schleimer","year":"1983","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaip.2023.02.017_bib22","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.jaci.2016.04.042","article-title":"Eosinophil production of prostaglandin D2 in patients with aspirin-exacerbated respiratory disease","volume":"138","author":"Feng","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.02.017_bib23","doi-asserted-by":"crossref","first-page":"7626","DOI":"10.1073\/pnas.80.24.7626","article-title":"Generation and metabolism of 5-ipoxygenase pathway leukotrienes by human eosinophils: predominant production of leukotriene C4","volume":"80","author":"Weller","year":"1983","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaip.2023.02.017_bib24","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1365-2222.2008.03104.x","article-title":"Increased production of cysteinyl leukotrienes and prostaglandin D2 during human anaphylaxis","volume":"39","author":"Ono","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2023.02.017_bib25","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1182\/blood.V29.5.722.722","article-title":"Release of histamine from human basophils","volume":"29","author":"Sampson","year":"1967","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2023.02.017_bib26","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.jaip.2022.03.008","article-title":"Nontryptase urinary and hematologic biomarkers of mast cell expansion and mast cell activation: status 2022","volume":"10","author":"Butterfield","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.02.017_bib27","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1159\/000506199","article-title":"Elevated serum tryptase in non-anaphylaxis cases: a concise review","volume":"181","author":"Lee","year":"2020","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2023.02.017_bib28","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.1365-2362.2009.02184.x","article-title":"Elevated tryptase levels selectively cluster in myeloid neoplasms: a novel diagnostic approach and screen marker in clinical haematology","volume":"39","author":"Sperr","year":"2009","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jaip.2023.02.017_bib29","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.molimm.2014.04.001","article-title":"Human mast cell tryptase in biology and medicine","volume":"63","author":"Vitte","year":"2015","journal-title":"Mol Immunol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219823002210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219823002210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:39:18Z","timestamp":1761975558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219823002210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S2213219823002210"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2023.02.017","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased Excretion of Mast Cell Mediator Metabolites During Mast Cell Activation Syndrome","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2023.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}